Inventor · disambiguated record
Laurence Boumsell
Also filed as: BOUMSELL LAURENCE
10 granted patents·6 pending applications·148 citations·filing 2001–2014
91Inventor score
Files withINST NAT SANTE RECH MED5BENSUSSAN ARMAND4BOUMSELL LAURENCE3BELIN MARIE-FRANCOISE2DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
16 records- 0191US7736647B2Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cellsMONOCLONAL ANTIBODIES THERAPEU·Filed 2005·Granted Jun 15, 2010·28 cites·12 claims
- 0290US7919085B2Means for the diagnosis and therapy of CTCLINST NAT SANTE RECH MED·Filed 2008·Granted Apr 5, 2011·14 cites·4 claims
- 0389US7700102B2Nucleic acids encoding CD100 moleculesDANA FARBER CANCER INST INC·Filed 2002·Granted Apr 20, 2010·23 cites·6 claims
- 0487US8409573B2Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cellsBOUMSELL LAURENCE·Filed 2006·Granted Apr 2, 2013·14 cites·5 claims
- 0586US8518655B2Means for the diagnosis and therapy of CTCLBENSUSSAN ARMAND·Filed 2012·Granted Aug 27, 2013·9 cites·13 claims
- 0686US8268308B2Means for the diagnosis and therapy of CTCLBENSUSSAN ARMAND·Filed 2011·Granted Sep 18, 2012·10 cites·12 claims
- 0781US8067247B2Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous systemBELIN MARIE-FRANCOISE·Filed 2004·Granted Nov 29, 2011·25 cites·4 claims
- 0880US7399595B2Means for the diagnosis and therapy of CTCLINST NAT SANTE RECH MED·Filed 2001·Granted Jul 15, 2008·11 cites·17 claims
- 0976US8679500B2Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseasesBOUMSELL LAURENCE·Filed 2010·Granted Mar 25, 2014·12 cites·10 claims
- 1070US8444978B2Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2BENSUSSAN ARMAND·Filed 2011·Granted May 21, 2013·2 cites·11 claims
- 1158US2015004170A1Angiogenic and Immunologic Applications of Anti-CD160 Specific Compounds Obtainable From mAb CL1-R2INST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 1253US2009317401A1Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2INST NAT SANTE RECH MED·Filed 2005·Application pending·0 cites
- 1352US2014120110A1ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2BENSUSSAN ARMAND·Filed 2013·Application pending·0 cites
- 1447US2010008932A1Use of soluble cd160 to suppress immunityINST NAT SANTE RECH MED·Filed 2007·Application pending·0 cites
- 1540US2012027758A1Use of anti-cd100 antibodiesBELIN MARIE-FRANCOISE·Filed 2011·Application pending·0 cites
- 1638US2013216476A1Use of an anti-cd71 antibody for preparing a medicamentBOUMSELL LAURENCE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →